XT
BLRX

XTX Topco’s BioLineRX BLRX Stock Holding History

XTX Topco’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3K Buy
+10,941
New +$30.7K ﹤0.01% 3492
2024
Q4 		– Sell
-1,103
Closed -$23.7K – 2316
2024
Q3 		$23.7K Buy
+1,103
New +$30.3K ﹤0.01% 1810
2024
Q2 		– Sell
-787
Closed -$35.3K – 1888
2024
Q1 		$35.3K Buy
+787
New +$39.5K ﹤0.01% 1530
2023
Q4 		– Sell
-584
Closed -$42.5K – 1619
2023
Q3 		$42.5K Buy
+584
New +$39.2K 0.01% 1296

Other funds holding BLRX

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

XTX Topco's BLRX Position: Q1 2026 in Review

XTX Topco opened a new position in BioLineRX (BLRX) in Q1 2026: 10,941 shares worth $25.3K. The stake represents ﹤0.01% of the portfolio and ranks #3492 among its holdings. This is a return to the name: XTX Topco previously reported a position in BLRX as recently as Q3 2024.

XTX Topco first reported a position in BLRX in Q3 2023 and has held it in 4 quarters since. The position peaked at $42.5K in Q3 2023. 13 funds tracked by Wall St. Rank hold BLRX as of Q1 2026.

  • XTX Topco held 10,941 shares of BioLineRX worth $25.3K as of Q1 2026.
  • BioLineRX was a new XTX Topco position in Q1 2026.
  • BioLineRX made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3492 holding.
  • XTX Topco first reported a position in BioLineRX in Q3 2023 and has held it in 4 quarters since.
  • XTX Topco's BioLineRX position peaked at $42.5K in Q3 2023.
  • 13 funds tracked by Wall St. Rank held BioLineRX as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.